Roopa Sethi

Buprenorphine is becoming the preferred treatment in pregnancy for opioid use disorder. But, women may need higher doses and multiple dosing schedules as pregnancy progresses to mitigate withdrawal symptoms...

Read a case report to find out more about Tapentadol and how it is often used for pain management, with low abuse potential.

This case report demonstrates the use of benzodiazepines to alleviate the withdrawal symptoms of phenibut in a 26-year-old man who visited the emergency department multiple times.

 

 

The opioid epidemic is receiving extensive attention and is largely attributed to a rise in nonmedical uses of prescription opioids. This case report highlights a dangerous new way some...

 

Here, read about the case of a 73-year-old man who developed hypotension, bradycardia, and possible respiratory depression following buprenorphine induction for opioid withdrawal.

 

Could prednisone therapy for Crohn's disease enhance buprenorphine metabolism, ultimately leading to a false-negative urine drug screen? Read this interesting case report to find out more.

 

Urine drug screens are often followed by confirmatory gas chromatography/mass spectrometry (GC/MS) tests. Periodically, GC/MS tests can have false-positive results. Read this case of a man with a past...

Use of high-potency cannabis derivatives has become increasingly popular over the past few years; however, their effects are not fully known. Here, read the case of a woman who...

Kratom has gained popularity as an inexpensive and accessible alternative to manage symptoms of opioid use disorder and pain. But, is it safe? This review provides the most up-to-date...

Kratom has emerged in the market as an herbal medication for pain management. However, it is not FDA approved or regulated, and there is very little research and reputable...

 

There are few data regarding alternative dosing regimens for depot injection naltrexone. Could more frequent dosing increase efficacy in patients who abuse alcohol? Read on to find out.

This case study contains important information for psychiatrists and addiction medicine specialists. It demonstrates how a patient may be bypassing a Medicaid Provider Lock-In and receiving relatively contraindicated medications.

There are multiple factors to consider while initiating medications for opioid use disorder. Mr A is a 66-year-old man with a 17-year history of opioid use for pain management...